Genetic	O
factors	O
in	O
human	O
sleep	O
disorders	O
with	O
special	O
reference	O
to	O
Norrie	O
disease	O
,	O
Prader	O
-	O
Willi	O
syndrome	O
and	O
Moebius	O
syndrome	O
.	O

Sleep	O
-	O
wake	O
problems	O
are	O
common	O
in	O
specific	O
inborn	O
errors	O
of	O
metabolism	O
and	O
structure	O
of	O
the	O
central	O
nervous	O
system	O
.	O

Psychological	O
factors	O
,	O
behavioural	O
difficulties	O
,	O
metabolic	O
disturbances	O
,	O
and	O
widespread	O
rather	O
than	O
focal	O
damage	O
to	O
the	O
nervous	O
system	O
are	O
present	O
in	O
many	O
of	O
these	O
diseases	O
and	O
all	O
influence	O
the	O
sleep	B-Sleep
-	I-Sleep
wake	I-Sleep
cycle	I-Sleep
.	O

However	O
,	O
a	O
number	O
of	O
conditions	O
cause	O
relatively	O
focal	O
damage	O
to	O
the	O
neuroanatomical	O
substrate	O
of	O
sleeping	B-Sleep
and	O
waking	B-Sleep
.	O

These	O
include	O
fatal	O
familial	O
insomnia	O
,	O
with	O
involvement	O
of	O
the	O
prion	O
protein	O
gene	O
on	O
chromosome	O
20	O
,	O
Norrie	O
disease	O
,	O
the	O
Prader	O
-	O
Willi	O
syndrome	O
and	O
the	O
Moebius	O
syndrome	O
.	O

The	O
last	O
three	O
important	O
conditions	O
,	O
although	O
rare	O
,	O
are	O
considered	O
in	O
detail	O
in	O
this	O
review	O
.	O

They	O
result	O
in	O
sensory	O
deprivation	O
,	O
hypothalamic	O
and	O
mid	O
-	O
brain	O
damage	O
,	O
and	O
involve	O
the	O
X	O
-	O
chromosome	O
,	O
chromosome	O
15	O
,	O
and	O
chromosome	O
13	O
,	O
respectively	O
.	O

These	O
conditions	O
cause	O
a	O
wide	O
variety	O
of	O
sleep	B-Sleep
disturbance	I-Sleep
,	O
including	O
parasomnias	O
,	O
daytime	B-Sleep
sleepiness	I-Sleep
,	O
and	O
a	O
condition	O
like	O
cataplexy	O
.	O

The	O
place	O
of	O
the	O
relevant	O
gene	O
products	O
in	O
normal	B-Sleep
sleep	I-Sleep
regulation	I-Sleep
needs	O
further	O
exploration	O
.	O

Cardiorespiratory	O
control	O
:	O
an	O
integrated	O
view	O
.	O

H	O
.	O
-	O
P	O
.	O

Koepchen	O
in	O
memoriam	O
.	O

H	O
.	O
-	O
P	O
.	O

Koepchen	O
'	O
s	O
presence	O
at	O
this	O
symposium	O
on	O
cardiocirculatory	O
function	O
during	O
sleep	B-Sleep
would	O
have	O
given	O
us	O
an	O
inspiring	O
impetus	O
.	O

His	O
death	O
has	O
meant	O
a	O
severe	O
loss	O
for	O
all	O
of	O
us	O
.	O

Koepchen	O
'	O
s	O
integrated	O
view	O
on	O
cardiorespiratory	O
control	O
and	O
rhythmicity	O
has	O
been	O
the	O
content	O
of	O
his	O
late	O
work	O
.	O

His	O
considerations	O
as	O
documented	O
in	O
various	O
papers	O
are	O
used	O
for	O
this	O
contribution	O
.	O

They	O
are	O
based	O
on	O
earlier	O
experimental	O
studies	O
of	O
spontaneous	O
coordinations	O
of	O
rhythmic	B-Physical_activity
activities	I-Physical_activity
in	O
anaesthetized	O
dogs	O
,	O
conscious	O
men	O
,	O
and	O
microelectrode	O
recordings	O
and	O
local	O
cooling	O
experiments	O
in	O
the	O
brain	O
stem	O
of	O
anaesthetized	O
dogs	O
and	O
cats	O
,	O
which	O
he	O
had	O
worked	O
on	O
together	O
with	O
his	O
students	O
.	O

Implementation	O
of	O
napping	B-Sleep
in	O
industry	O
and	O
the	O
problem	O
of	O
sleep	B-Sleep
inertia	I-Sleep
.	O

It	O
seems	O
reasonable	O
to	O
believe	O
that	O
in	O
specific	O
situations	O
napping	B-Sleep
at	O
the	O
work	B-Socioeconomic_factors
place	I-Socioeconomic_factors
would	O
be	O
possible	O
and	O
used	O
if	O
authorized	O
and	O
encouraged	O
.	O

Very	B-Sleep
short	I-Sleep
naps	I-Sleep
could	O
have	O
very	O
positive	O
long	O
-	O
term	O
effects	O
on	O
biological	O
functions	O
.	O

Training	O
someone	O
to	O
sleep	B-Sleep
for	I-Sleep
short	I-Sleep
periods	I-Sleep
appears	O
feasible	O
if	O
there	O
is	O
a	O
high	O
motivation	O
to	O
do	O
so	O
.	O

Sleep	B-Sleep
inertia	I-Sleep
can	O
be	O
considered	O
as	O
one	O
of	O
the	O
main	O
limiting	O
factors	O
in	O
napping	B-Sleep
strategy	O
.	O

Sleep	B-Sleep
inertia	I-Sleep
depends	O
on	O
different	O
factors	O
such	O
as	O
sleep	B-Sleep
stage	I-Sleep
preceding	O
the	O
awakening	O
,	O
temporal	O
placement	O
of	O
the	O
nap	B-Sleep
,	O
duration	B-Sleep
of	I-Sleep
nap	I-Sleep
and	O
wakefulness	B-Sleep
preceding	O
it	O
,	O
etc	O
.	O

The	O
effects	O
of	O
sleep	B-Sleep
inertia	I-Sleep
might	O
be	O
different	O
depending	O
on	O
the	O
type	O
of	O
task	O
,	O
and	O
a	O
reactivation	O
technique	O
applied	O
immediately	O
after	O
awakening	O
may	O
remove	O
it	O
.	O

Despite	O
the	O
fact	O
that	O
its	O
implementation	O
in	O
industry	O
raises	O
some	O
practical	O
issues	O
,	O
napping	B-Sleep
can	O
be	O
considered	O
as	O
a	O
possible	O
strategy	O
to	O
increase	O
the	O
vigilance	O
level	O
of	O
night	B-Socioeconomic_factors
workers	I-Socioeconomic_factors
.	O

Characteristics	O
of	O
DSM	O
-	O
IV	O
and	O
ICD	O
-	O
10	O
cannabis	B-Drugs
dependence	I-Drugs
among	O
Australian	O
adults	O
:	O
results	O
from	O
the	O
National	O
Survey	O
of	O
Mental	O
Health	O
and	O
Wellbeing	O
.	O

A	O
representative	O
sample	O
(	O
n	O
=	O
10641	O
)	O
of	O
Australian	O
adults	O
completed	O
a	O
structured	O
diagnostic	O
interview	O
assessing	O
the	O
prevalence	O
of	O
mental	O
and	O
substance	O
use	O
disorders	O
in	O
the	O
last	O
year	O
.	O

The	O
prevalence	O
of	O
DSM	O
-	O
IV	O
(	O
1	O
.	O
5	O
%	O
)	O
and	O
ICD	O
-	O
10	O
(	O
1	O
.	O
7	O
%	O
)	O
cannabis	B-Drugs
dependence	I-Drugs
was	O
similar	O
.	O

DSM	O
-	O
IV	O
and	O
ICD	O
-	O
10	O
dependence	O
criteria	O
comprised	O
unidimensional	O
syndromes	O
.	O

The	O
most	O
common	O
symptoms	O
among	O
dependent	O
and	O
non	O
-	O
dependent	O
users	O
were	O
difficulties	O
with	O
controlling	O
use	O
and	O
withdrawal	O
,	O
although	O
there	O
were	O
marked	O
differences	O
in	O
symptom	O
prevalence	O
.	O

Dependent	O
users	O
reported	O
a	O
median	O
of	O
four	O
symptoms	O
.	O

There	O
was	O
good	O
to	O
excellent	O
diagnostic	O
concordance	O
(	O
kappas	O
=	O
0	O
.	O
7	O
-	O
0	O
.	O
9	O
)	O
between	O
systems	O
for	O
dependence	O
but	O
not	O
for	O
abuse	O
/	O
harmful	O
use	O
(	O
Y	O
=	O
0	O
.	O
4	O
)	O
.	O

These	O
findings	O
provide	O
some	O
support	O
for	O
the	O
validity	O
of	O
cannabis	B-Drugs
dependence	I-Drugs
.	O

A	O
randomized	O
controlled	O
trial	O
to	O
investigate	O
brackets	O
bonded	O
with	O
a	O
hydrophilic	O
primer	O
.	O

OBJECTIVE	O
:	O
To	O
compare	O
the	O
clinical	O
failure	O
rates	O
of	O
brackets	O
bonded	O
using	O
a	O
prototype	O
hydrophilic	O
primer	O
,	O
designed	O
to	O
be	O
insensitive	O
to	O
moisture	O
,	O
with	O
brackets	O
bonded	O
with	O
a	O
conventional	O
primer	O
.	O

DESIGN	O
:	O
Single	O
centre	O
randomised	O
controlled	O
clinical	O
study	O
.	O

Thirty	O
-	O
three	O
patients	O
were	O
bonded	O
using	O
a	O
split	O
mouth	O
technique	O
:	O
randomly	O
allocating	O
the	O
hydrophilic	O
primer	O
to	O
one	O
side	O
of	O
the	O
mouth	O
and	O
a	O
conventional	O
primer	O
to	O
the	O
other	O
.	O

SETTING	O
:	O
Hospital	O
orthodontic	O
department	O
,	O
Bradford	O
,	O
UK	O
.	O

SUBJECTS	O
:	O
Orthodontic	O
patients	O
requiring	O
fixed	O
appliances	O
.	O

MAIN	O
OUTCOME	O
MEASURES	O
:	O
The	O
site	O
and	O
time	O
to	O
bond	O
failure	O
was	O
recorded	O
for	O
each	O
bracket	O
that	O
failed	O
over	O
6	O
months	O
.	O

RESULTS	O
:	O
Using	O
survival	O
analysis	O
,	O
there	O
was	O
an	O
increased	O
risk	O
of	O
bracket	O
failure	O
when	O
bonded	O
with	O
the	O
hydrophilic	O
primer	O
compared	O
with	O
the	O
conventional	O
primer	O
(	O
hazard	O
ratio	O
=	O
2	O
.	O
2	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
1	O
.	O
1	O
to	O
4	O
.	O
5	O
,	O
P	O
=	O
0	O
.	O
01	O
)	O
.	O

CONCLUSIONS	O
:	O
This	O
hydrophilic	O
primer	O
cannot	O
be	O
recommended	O
for	O
routine	O
clinical	O
use	O
.	O

Clinical	O
symptomatology	O
and	O
treatment	O
of	O
restless	O
legs	O
syndrome	O
and	O
periodic	O
limb	O
movement	O
disorder	O
.	O

Patients	O
with	O
restless	O
legs	O
syndrome	O
(	O
RLS	O
)	O
suffer	O
from	O
sensory	O
and	O
motor	O
symptoms	O
evoked	O
in	O
the	O
limbs	O
at	O
rest	O
.	O

Symptoms	O
increase	O
in	O
the	O
evening	O
and	O
during	O
the	O
night	O
.	O

The	O
circadian	B-Sleep
rhythm	I-Sleep
and	O
the	O
presence	O
of	O
involuntary	O
periodic	O
limb	O
movement	O
in	O
sleep	B-Sleep
(	O
PLMS	O
)	O
which	O
are	O
frequently	O
associated	O
with	O
arousals	O
probably	O
cause	O
the	O
leading	O
symptom	O
of	O
sleep	B-Sleep
disturbances	I-Sleep
in	O
RLS	O
.	O

Patients	O
who	O
do	O
not	O
have	O
typical	O
RLS	O
symptoms	O
but	O
whose	O
polysomnography	O
shows	O
PLMS	O
that	O
either	O
impact	O
on	O
sleep	B-Sleep
continuity	I-Sleep
or	O
daytime	O
functioning	O
are	O
diagnosed	O
as	O
having	O
the	O
periodic	O
limb	O
movement	O
disorder	O
(	O
PLMD	O
)	O
.	O

Dopaminergic	O
agents	O
such	O
as	O
levodopa	O
/	O
dopa	O
decarboxylase	O
inhibitor	O
(	O
DDI	O
)	O
and	O
dopamine	O
agonists	O
are	O
considered	O
the	O
treatment	O
of	O
choice	O
for	O
RLS	O
and	O
PLMS	O
.	O

This	O
article	O
gives	O
an	O
overview	O
of	O
the	O
epidemiology	O
,	O
pathophysiology	O
,	O
clinical	O
symptomatology	O
and	O
diagnosis	O
of	O
RLS	O
and	O
PLMD	O
and	O
focuses	O
on	O
treatment	O
strategies	O
in	O
both	O
disorders	O
.	O

Orbital	O
fractures	O
in	O
sport	B-Physical_activity
:	O
a	O
review	O
.	O

Orbital	O
fractures	O
represent	O
a	O
small	O
proportion	O
of	O
sports	B-Physical_activity
-	O
related	O
injuries	O
in	O
the	O
US	O
and	O
abroad	O
.	O

However	O
,	O
the	O
significant	O
functional	O
and	O
cosmetic	O
sequelae	O
of	O
such	O
fractures	O
warrant	O
a	O
comprehensive	O
evaluation	O
of	O
any	O
athlete	O
sustaining	O
facial	O
trauma	O
.	O

Initial	O
evaluation	O
is	O
directed	O
at	O
excluding	O
neurological	O
impairment	O
or	O
the	O
presence	O
of	O
vision	O
-	O
threatening	O
injury	O
.	O

Subsequent	O
examination	O
should	O
ascertain	O
the	O
presence	O
of	O
signs	O
and	O
symptoms	O
consistent	O
with	O
orbital	O
fracture	O
.	O

These	O
include	O
gross	O
bony	O
deformity	O
,	O
limitation	O
of	O
gaze	O
,	O
diplopia	O
and	O
malposition	O
of	O
the	O
globe	O
.	O

The	O
presence	O
of	O
any	O
of	O
the	O
aforementioned	O
symptoms	O
should	O
prompt	O
further	O
investigation	O
using	O
computed	O
tomography	O
to	O
corroborate	O
or	O
refute	O
clinical	O
suspicion	O
.	O

Orbital	O
fracture	O
mandates	O
referral	O
to	O
an	O
ophthalmologist	O
or	O
oculoplastic	O
surgeon	O
;	O
initial	O
management	O
is	O
dictated	O
by	O
the	O
severity	O
of	O
functional	O
symptoms	O
,	O
and	O
may	O
necessitate	O
early	O
surgical	O
intervention	O
.	O

Those	O
patients	O
who	O
are	O
managed	O
conservatively	O
should	O
return	O
for	O
frequent	O
follow	O
-	O
up	O
,	O
as	O
progressive	O
diplopia	O
,	O
enophthalmos	O
,	O
or	O
gaze	O
limitation	O
are	O
indications	O
for	O
late	O
operative	O
repair	O
.	O

The	O
majority	O
of	O
patients	O
who	O
sustain	O
orbital	O
fractures	O
are	O
able	O
to	O
return	O
to	O
sport	B-Physical_activity
,	O
however	O
,	O
persistent	O
diplopia	O
is	O
not	O
uncommon	O
,	O
and	O
may	O
persist	O
despite	O
optimal	O
treatment	O
.	O

Smile	O
aesthetics	O
and	O
malocclusion	O
in	O
UK	O
teenage	O
magazines	O
assessed	O
using	O
the	O
Index	O
of	O
Orthodontic	B-Beauty_and_Cleaning
Treatment	I-Beauty_and_Cleaning
Need	O
(	O
IOTN	O
)	O
.	O

OBJECTIVE	O
:	O
There	O
is	O
a	O
significant	O
demand	O
for	O
orthodontic	B-Beauty_and_Cleaning
treatment	I-Beauty_and_Cleaning
within	O
the	O
UK	O
from	O
adolescent	O
girls	O
,	O
a	O
group	O
known	O
to	O
be	O
influenced	O
by	O
the	O
media	O
portrayal	O
of	O
body	O
form	O
and	O
body	O
image	O
,	O
which	O
may	O
extend	O
to	O
the	O
presentation	O
of	O
malocclusions	O
.	O

This	O
study	O
examined	O
the	O
portrayal	O
of	O
malocclusion	O
in	O
a	O
media	O
type	O
that	O
targets	O
teenage	O
girls	O
under	O
16	O
years	O
of	O
age	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
A	O
representative	O
selection	O
of	O
1	O
month	O
'	O
s	O
magazines	O
targeting	O
this	O
group	O
were	O
investigated	O
,	O
and	O
the	O
frequency	O
and	O
severity	O
of	O
malocclusions	O
displayed	O
were	O
assessed	O
.	O

Two	O
calibrated	O
examiners	O
viewed	O
all	O
the	O
smiles	O
(	O
on	O
two	O
occasions	O
)	O
using	O
a	O
modification	O
of	O
Index	O
of	O
Orthodontic	B-Beauty_and_Cleaning
Treatment	I-Beauty_and_Cleaning
Need	O
(	O
IOTN	O
)	O
and	O
assigned	O
an	O
Aesthetic	O
Component	O
Score	O
to	O
each	O
smile	O
.	O

RESULTS	O
:	O
It	O
was	O
found	O
that	O
the	O
aesthetic	O
score	O
is	O
low	O
(	O
less	O
than	O
7	O
)	O
for	O
the	O
majority	O
of	O
models	O
(	O
92	O
.	O
8	O
%	O
)	O
indicating	O
no	O
need	O
or	O
a	O
borderline	O
need	O
for	O
treatment	O
.	O

Only	O
7	O
.	O
2	O
%	O
of	O
models	O
exhibited	O
a	O
definite	O
need	O
for	O
treatment	O
.	O

CONCLUSION	O
:	O
It	O
appears	O
that	O
the	O
portrayal	O
of	O
malocclusion	O
in	O
teenage	O
magazines	O
does	O
not	O
reflect	O
the	O
general	O
treatment	O
need	O
of	O
the	O
adolescent	O
population	O
.	O

The	O
relationship	O
between	O
daytime	B-Environmental_exposures
exposure	I-Environmental_exposures
to	I-Environmental_exposures
light	I-Environmental_exposures
and	O
night	B-Sleep
-	I-Sleep
time	I-Sleep
sleep	I-Sleep
in	O
6	O
-	O
12	O
-	O
week	O
-	O
old	O
infants	O
.	O

This	O
project	O
investigated	O
the	O
relationship	O
between	O
exposure	B-Environmental_exposures
to	I-Environmental_exposures
light	I-Environmental_exposures
and	O
24	O
-	O
h	O
patterns	B-Sleep
of	I-Sleep
sleep	I-Sleep
and	O
crying	O
in	O
young	O
,	O
healthy	O
,	O
full	O
-	O
term	O
babies	O
living	O
at	O
home	O
and	O
following	O
a	O
normal	O
domestic	O
routine	O
.	O

Measures	O
included	O
an	O
ankle	O
worn	O
activity	O
monitor	O
,	O
an	O
external	O
light	O
monitor	O
and	O
the	O
Barr	O
Baby	O
Day	O
Diary	O
in	O
which	O
parents	O
recorded	O
periods	B-Sleep
of	I-Sleep
sleep	I-Sleep
,	O
crying	O
,	O
feeding	O
and	O
other	O
behaviours	O
at	O
5	O
-	O
min	O
intervals	O
throughout	O
the	O
24	O
-	O
h	O
period	O
.	O

Fifty	O
-	O
six	O
babies	O
(	O
26	O
males	O
and	O
30	O
females	O
)	O
were	O
monitored	O
across	O
three	O
consecutive	O
days	O
at	O
6	O
,	O
9	O
and	O
12	O
weeks	O
of	O
age	O
.	O

There	O
was	O
an	O
early	O
evening	O
peak	O
in	O
crying	O
which	O
was	O
associated	O
with	O
reduced	B-Sleep
sleep	I-Sleep
at	O
6	O
weeks	O
.	O

Across	O
the	O
trials	O
there	O
was	O
a	O
gradual	O
shift	O
towards	O
a	O
greater	O
proportion	O
of	O
sleep	B-Sleep
occurring	O
at	O
night	O
.	O

Sleeping	B-Sleep
well	O
at	O
6	O
weeks	O
was	O
a	O
good	O
indication	O
of	O
more	O
night	B-Sleep
-	I-Sleep
time	I-Sleep
sleep	I-Sleep
at	O
9	O
and	O
12	O
weeks	O
.	O

Babies	O
who	O
slept	B-Sleep
well	I-Sleep
at	I-Sleep
night	I-Sleep
were	O
exposed	B-Environmental_exposures
to	I-Environmental_exposures
significantly	I-Environmental_exposures
more	I-Environmental_exposures
light	I-Environmental_exposures
in	O
the	O
early	O
afternoon	O
period	O
.	O

These	O
data	O
suggest	O
that	O
light	B-Environmental_exposures
in	O
the	O
normal	O
domestic	O
setting	O
influences	O
the	O
development	O
of	O
the	O
circadian	B-Sleep
system	I-Sleep
.	O

A	O
review	O
on	O
pharmacological	O
activities	O
and	O
utilization	O
technologies	O
of	O
pumpkin	B-Nutrition
.	O

Dietary	B-Nutrition
plants	I-Nutrition
and	O
herbal	B-Nutrition
preparations	I-Nutrition
have	O
been	O
traditionally	O
used	O
as	O
medicine	O
in	O
developing	B-Socioeconomic_factors
countries	I-Socioeconomic_factors
and	O
obtained	O
a	O
resurgence	O
of	O
use	O
in	O
the	O
United	O
States	O
and	O
Europe	O
.	O

Research	O
carried	O
out	O
in	O
last	O
few	O
decades	O
has	O
validated	O
several	O
such	O
claims	O
of	O
use	O
of	O
traditional	B-Nutrition
medicine	I-Nutrition
plants	I-Nutrition
.	O

Popularity	O
of	O
pumpkin	B-Nutrition
in	O
various	O
systems	O
of	O
traditional	O
medicine	O
for	O
several	O
ailments	O
(	O
antidiabetic	O
,	O
antihypertensive	O
,	O
antitumor	O
,	O
immunomodulation	O
,	O
antibacterial	O
,	O
antihypercholesterolemia	O
,	O
intestinal	O
antiparasitia	O
,	O
antiinflammation	O
,	O
antalgic	O
)	O
focused	O
the	O
investigators	O
'	O
attention	O
on	O
this	O
plant	B-Nutrition
.	O

Considerable	O
evidence	O
from	O
several	O
epidemiological	O
studies	O
concerning	O
bioactivities	O
leads	O
have	O
stimulated	O
a	O
number	O
of	O
animal	O
model	O
,	O
cell	O
culture	O
studies	O
and	O
clinical	O
trials	O
designed	O
to	O
test	O
this	O
pharmacological	O
actions	O
.	O

In	O
addition	O
,	O
it	O
was	O
found	O
that	O
technologies	O
such	O
as	O
germination	O
and	O
fermentation	O
could	O
reduce	O
antinutritional	O
materials	O
and	O
affect	O
the	O
pharmacological	O
activities	O
of	O
pumpkin	B-Nutrition
.	O

This	O
review	O
will	O
focus	O
on	O
the	O
main	O
medicinal	O
properties	O
and	O
technologies	O
of	O
pumpkin	B-Nutrition
,	O
and	O
point	O
out	O
areas	O
for	O
future	O
research	O
to	O
further	O
elucidate	O
mechanisms	O
whereby	O
this	O
compound	O
may	O
reduce	O
disease	O
risk	O
.	O

Who	O
are	O
the	O
long	B-Sleep
sleepers	I-Sleep
?	O

Towards	O
an	O
understanding	O
of	O
the	O
mortality	O
relationship	O
.	O

While	O
much	O
is	O
known	O
about	O
the	O
negative	O
health	O
implications	O
of	O
insufficient	B-Sleep
sleep	I-Sleep
,	O
relatively	O
little	O
is	O
known	O
about	O
risks	O
associated	O
with	O
excessive	B-Sleep
sleep	I-Sleep
.	O

However	O
,	O
epidemiological	O
studies	O
have	O
repeatedly	O
found	O
a	O
mortality	O
risk	O
associated	O
with	O
reported	O
habitual	B-Sleep
long	I-Sleep
sleep	I-Sleep
.	O

This	O
paper	O
will	O
summarize	O
and	O
describe	O
the	O
numerous	O
studies	O
demonstrating	O
increased	O
mortality	O
risk	O
associated	O
with	O
long	B-Sleep
sleep	I-Sleep
.	O

Although	O
these	O
studies	O
establish	O
a	O
mortality	O
link	O
,	O
they	O
do	O
not	O
sufficiently	O
explain	O
why	O
such	O
a	O
relationship	O
might	O
occur	O
.	O

Possible	O
mechanisms	O
for	O
this	O
relationship	O
will	O
be	O
proposed	O
and	O
described	O
,	O
including	O
(	O
1	O
)	O
sleep	B-Sleep
fragmentation	I-Sleep
,	O
(	O
2	O
)	O
fatigue	O
,	O
(	O
3	O
)	O
immune	O
function	O
,	O
(	O
4	O
)	O
photoperiodic	O
abnormalities	O
,	O
(	O
5	O
)	O
lack	B-Socioeconomic_factors
of	I-Socioeconomic_factors
challenge	I-Socioeconomic_factors
,	O
(	O
6	O
)	O
depression	O
,	O
or	O
(	O
7	O
)	O
underlying	O
disease	O
process	O
such	O
as	O
(	O
a	O
)	O
sleep	O
apnea	O
,	O
(	O
b	O
)	O
heart	O
disease	O
,	O
or	O
(	O
c	O
)	O
failing	O
health	O
.	O

Following	O
this	O
,	O
we	O
will	O
take	O
a	O
step	O
back	O
and	O
carefully	O
consider	O
all	O
of	O
the	O
historical	O
and	O
current	O
literature	O
regarding	O
long	B-Sleep
sleep	I-Sleep
,	O
to	O
determine	O
whether	O
the	O
scientific	O
evidence	O
supports	O
these	O
proposed	O
mechanisms	O
and	O
ascertain	O
what	O
future	O
research	O
directions	O
may	O
clarify	O
or	O
test	O
these	O
hypotheses	O
regarding	O
the	O
relationship	O
between	O
long	B-Sleep
sleep	I-Sleep
and	O
mortality	O
.	O

How	O
tobacco	B-Drugs
protects	O
you	O
against	O
the	O
flu	O
.	O

Under	O
the	O
heading	O
"	O
How	O
tobacco	B-Drugs
protects	O
you	O
against	O
the	O
flu	O
"	O
,	O
the	O
German	O
chemical	B-Environmental_exposures
industry	I-Environmental_exposures
portrays	O
a	O
tobacco	B-Drugs
grower	O
in	O
an	O
idyllic	O
tobacco	B-Drugs
plantation	O
.	O

Despite	O
the	O
recent	O
ban	O
of	O
transnational	O
tobacco	B-Drugs
advertising	O
within	O
the	O
European	O
Union	O
,	O
using	O
tobacco	B-Drugs
to	O
promote	O
another	O
industry	O
and	O
potential	O
societal	O
health	O
benefits	O
might	O
indirectly	O
promote	O
the	O
social	O
acceptability	O
of	O
tobacco	B-Drugs
to	O
social	O
leaders	O
.	O

The	O
tobacco	B-Drugs
control	O
community	O
should	O
thus	O
monitor	O
the	O
use	O
of	O
other	O
industries	O
as	O
a	O
new	O
method	O
to	O
circumvent	O
the	O
tobacco	B-Drugs
advertising	O
ban	O
and	O
to	O
support	O
the	O
social	O
acceptability	O
of	O
tobacco	B-Drugs
by	O
associating	O
it	O
with	O
potential	O
health	O
benefits	O
.	O

Brain	O
activity	O
during	O
anticipation	O
of	O
smoking	B-Drugs
-	O
related	O
and	O
emotionally	O
positive	O
pictures	O
in	O
smokers	O
and	O
nonsmokers	O
:	O
a	O
new	O
measure	O
of	O
cue	O
reactivity	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
a	O
brain	O
wave	O
pattern	O
known	O
as	O
stimulus	O
preceding	O
negativity	O
(	O
SPN	O
)	O
can	O
index	O
the	O
anticipation	O
of	O
motivationally	O
relevant	O
events	O
.	O

The	O
present	O
study	O
was	O
the	O
first	O
to	O
use	O
SPN	O
as	O
an	O
index	O
of	O
the	O
motivational	O
significance	O
of	O
smoking	B-Drugs
-	O
related	O
pictures	O
.	O

Emotionally	O
positive	O
and	O
neutral	O
pictures	O
served	O
as	O
controls	O
.	O

The	O
paradigm	O
involved	O
the	O
following	O
sequence	O
:	O
(	O
a	O
)	O
presentation	O
of	O
a	O
picture	O
(	O
S1	O
)	O
for	O
500	O
ms	O
,	O
(	O
b	O
)	O
a	O
fixation	O
cross	O
for	O
3	O
,	O
500	O
ms	O
,	O
(	O
c	O
)	O
a	O
second	O
presentation	O
(	O
S2	O
)	O
of	O
the	O
same	O
picture	O
for	O
2	O
,	O
000	O
ms	O
,	O
and	O
(	O
d	O
)	O
another	O
fixation	O
cross	O
signifying	O
the	O
beginning	O
of	O
a	O
new	O
S1	O
-	O
S2	O
trial	O
using	O
a	O
different	O
picture	O
.	O

The	O
participants	O
(	O
N	O
=	O
24	O
,	O
half	O
smokers	O
and	O
half	O
nonsmokers	O
)	O
viewed	O
pictures	O
from	O
three	O
categories	O
(	O
smoking	B-Drugs
-	O
related	O
,	O
emotionally	O
positive	O
,	O
or	O
emotionally	O
neutral	O
)	O
.	O

Consistent	O
with	O
predictions	O
,	O
smokers	O
exhibited	O
significantly	O
greater	O
mean	O
SPN	O
amplitudes	O
in	O
anticipation	O
of	O
smoking	B-Drugs
-	O
related	O
pictures	O
relative	O
to	O
neutral	O
pictures	O
.	O

Among	O
nonsmokers	O
the	O
SPN	O
was	O
significantly	O
smaller	O
in	O
anticipation	O
of	O
smoking	B-Drugs
pictures	O
compared	O
with	O
neutral	O
pictures	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
the	O
incentive	O
sensitization	O
theory	O
of	O
addiction	B-Drugs
and	O
other	O
conditioning	O
and	O
cue	O
-	O
reactivity	O
models	O
.	O

Effects	O
of	O
high	O
-	O
AGE	O
beverage	B-Nutrition
on	O
RAGE	O
and	O
VEGF	O
expressions	O
in	O
the	O
liver	O
and	O
kidneys	O
.	O

BACKGROUND	O
:	O
The	O
formation	O
and	O
accumulation	O
of	O
advanced	O
glycation	O
end	O
products	O
(	O
AGEs	O
)	O
increase	O
in	O
some	O
lifestyle	O
-	O
related	O
diseases	O
as	O
well	O
as	O
in	O
aging	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
the	O
relationship	O
between	O
food	B-Nutrition
-	O
derived	O
AGEs	O
and	O
the	O
pathology	O
of	O
such	O
diseases	O
.	O

AIM	O
OF	O
THE	O
STUDY	O
AND	O
METHODS	O
:	O
To	O
explore	O
whether	O
food	B-Nutrition
items	O
containing	O
high	O
levels	O
of	O
AGEs	O
are	O
involved	O
in	O
the	O
development	O
of	O
lifestyle	O
-	O
related	O
diseases	O
,	O
rats	O
were	O
orally	O
administered	O
a	O
commercial	O
high	O
-	O
AGE	O
beverage	B-Nutrition
[	O
Lactobacillus	O
beverage	O
-	O
A	O
(	O
LB	O
-	O
A	O
)	O
]	O
.	O

With	O
a	O
particular	O
focus	O
on	O
angiogenesis	O
-	O
associated	O
diseases	O
,	O
the	O
gene	O
expressions	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
and	O
the	O
receptor	O
for	O
AGEs	O
(	O
RAGE	O
)	O
were	O
examined	O
in	O
the	O
liver	O
and	O
kidneys	O
using	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
.	O

Moreover	O
,	O
AGE	O
deposition	O
was	O
immunohistochemically	O
investigated	O
in	O
these	O
tissues	O
.	O

RESULTS	O
AND	O
CONCLUSIONS	O
:	O
Hepatic	O
VEGF	O
expression	O
was	O
significantly	O
increased	O
in	O
rats	O
administered	O
LB	O
-	O
A	O
(	O
P	O
<	O
0	O
.	O
01	O
vs	O
.	O
control	O
)	O
.	O

Furthermore	O
,	O
immunohistochemical	O
analysis	O
detected	O
glucose	O
-	O
derived	O
AGE	O
-	O
positive	O
cells	O
in	O
the	O
liver	O
from	O
the	O
LB	O
-	O
A	O
group	O
.	O

These	O
results	O
suggest	O
that	O
AGE	O
-	O
rich	O
beverages	B-Nutrition
increase	O
hepatic	O
VEGF	O
expression	O
and	O
AGE	O
accumulation	O
,	O
bringing	O
about	O
early	O
events	O
associated	O
with	O
lifestyle	O
-	O
related	O
diseases	O
.	O

Prodynorphin	O
gene	O
deficiency	O
potentiates	O
nalbuphine	O
-	O
induced	O
behavioral	O
sensitization	O
and	O
withdrawal	O
syndrome	O
in	O
mice	O
.	O

Dynorphin	O
is	O
the	O
presumed	O
endogenous	O
ligand	O
for	O
the	O
kappa	O
-	O
opioid	O
receptor	O
.	O

The	O
dynorphin	O
gene	O
may	O
play	O
a	O
role	O
in	O
psychotropic	O
agent	O
-	O
mediated	O
behavioral	O
changes	O
via	O
dopaminergic	O
modulation	O
.	O

Therefore	O
,	O
in	O
this	O
study	O
,	O
possible	O
involvement	O
of	O
the	O
dynorphin	O
gene	O
in	O
nalbuphine	O
-	O
mediated	O
behavioral	O
responses	O
was	O
examined	O
using	O
prodynorphin	O
(	O
Pdyn	O
)	O
gene	O
knock	O
-	O
out	O
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

Pdyn	O
gene	O
deficiency	O
potentiates	O
nalbuphine	O
-	O
induced	O
behavioral	O
sensitization	O
of	O
locomotor	O
activity	O
and	O
accumbal	O
c	O
-	O
Fos	O
expression	O
.	O

Administration	O
of	O
nalbuphine	O
induced	O
a	O
significant	O
increase	O
in	O
the	O
dialysate	O
dopamine	O
level	O
in	O
the	O
nucleus	O
accumbens	O
.	O

This	O
increase	O
was	O
more	O
pronounced	O
in	O
the	O
Pdyn	O
(	O
-	O
/	O
-	O
)	O
mice	O
than	O
in	O
the	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	O
.	O

In	O
addition	O
,	O
Pdyn	O
(	O
-	O
/	O
-	O
)	O
mice	O
were	O
more	O
vulnerable	O
to	O
the	O
naloxone	O
-	O
precipitated	O
withdrawal	O
syndrome	O
(	O
i	O
.	O
e	O
.	O
,	O
teeth	O
chattering	O
,	O
wet	O
dog	O
shakes	O
,	O
forepaw	O
tremors	O
,	O
jumping	O
,	O
weight	O
loss	O
,	O
and	O
global	O
withdrawal	O
score	O
)	O
after	O
repeated	O
treatment	O
with	O
nalbuphine	O
than	O
the	O
WT	O
mice	O
.	O

Consistently	O
,	O
nor	O
-	O
binaltorphimine	O
,	O
a	O
kappa	O
-	O
opioid	O
receptor	O
antagonist	O
,	O
significantly	O
potentiated	O
nalbuphine	O
-	O
induced	O
behavioral	O
effects	O
in	O
WT	O
mice	O
,	O
whereas	O
U	O
-	O
50488H	O
,	O
a	O
kappa	O
-	O
opioid	O
receptor	O
agonist	O
,	O
significantly	O
attenuated	O
these	O
changes	O
in	O
Pdyn	O
(	O
-	O
/	O
-	O
)	O
mice	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
kappa	O
-	O
opioid	O
receptor	O
/	O
dynorphin	O
system	O
is	O
specifically	O
modulated	O
in	O
response	O
to	O
behavioral	O
sensitization	O
and	O
withdrawal	O
signs	O
induced	O
by	O
nalbuphine	O
.	O

Group	B-Mental_health_practices
therapy	I-Mental_health_practices
module	O
to	O
enhance	O
self	O
-	O
esteem	O
in	O
patients	O
with	O
borderline	O
personality	O
disorder	O
:	O
a	O
pilot	O
study	O
.	O

Psychotherapeutic	B-Mental_health_practices
treatments	I-Mental_health_practices
of	O
borderline	O
personality	O
disorder	O
(	O
BPD	O
)	O
often	O
focus	O
on	O
severe	O
behavioral	O
problems	O
.	O

Until	O
now	O
,	O
few	O
techniques	O
have	O
been	O
developed	O
to	O
specifically	O
address	O
low	O
self	O
-	O
esteem	O
in	O
BPD	O
.	O

We	O
developed	O
a	O
6	O
-	O
session	O
psychoeducative	O
group	O
therapy	O
module	O
to	O
treat	O
low	O
self	O
-	O
esteem	O
in	O
BPD	O
patients	O
.	O

After	O
developing	O
and	O
piloting	O
the	O
therapy	O
module	O
,	O
a	O
controlled	O
outpatient	O
pilot	O
study	O
was	O
performed	O
.	O

Nineteen	O
female	O
BPD	O
patients	O
participated	O
in	O
the	O
group	O
module	O
after	O
discharge	O
from	O
an	O
inpatient	O
DBT	O
program	O
.	O

Twenty	O
-	O
four	O
female	O
BPD	O
patients	O
served	O
as	O
controls	O
.	O

Outcome	O
was	O
assessed	O
by	O
different	O
self	O
-	O
esteem	O
measures	O
.	O

Results	O
showed	O
a	O
greater	O
improvement	O
in	O
self	O
-	O
esteem	O
in	O
the	O
intervention	O
group	O
.	O

The	O
findings	O
suggest	O
that	O
the	O
therapy	O
module	O
is	O
an	O
effective	O
adjunctive	O
treatment	O
in	O
increasing	O
self	O
-	O
esteem	O
in	O
BPD	O
.	O

Occupational	B-Socioeconomic_factors
physical	I-Socioeconomic_factors
activity	I-Socioeconomic_factors
and	O
the	O
metabolic	O
syndrome	O
among	O
working	O
women	O
:	O
a	O
Go	O
Red	O
North	O
Dakota	O
study	O
.	O

OBJECTIVE	O
:	O
To	O
examine	O
the	O
association	O
of	O
metabolic	O
syndrome	O
(	O
MetSyn	O
)	O
with	O
occupational	B-Physical_activity
physical	I-Physical_activity
activity	I-Physical_activity
(	O
OCPA	B-Physical_activity
)	O
and	O
leisure	B-Physical_activity
-	I-Physical_activity
time	I-Physical_activity
physical	I-Physical_activity
activity	I-Physical_activity
(	O
LTPA	B-Physical_activity
)	O
among	O
working	O
women	O
.	O

METHODS	O
:	O
The	O
prevalence	O
of	O
MetSyn	O
was	O
calculated	O
for	O
642	O
working	O
women	O
.	O

Self	O
-	O
report	O
questionnaire	O
was	O
used	O
to	O
determine	O
levels	O
of	O
OCPA	B-Socioeconomic_factors
and	O
LTPA	B-Physical_activity
and	O
other	O
lifestyle	B-Lifestyle_factor
factors	I-Lifestyle_factor
.	O

Biometric	O
data	O
were	O
directly	O
collected	O
on	O
all	O
women	O
.	O

RESULTS	O
:	O
No	O
direct	O
relationship	O
for	O
OCPA	B-Socioeconomic_factors
and	O
the	O
MetSyn	O
was	O
determined	O
.	O

Sufficient	O
LTPA	B-Physical_activity
however	O
,	O
was	O
significantly	O
associated	O
with	O
lower	O
prevalence	O
of	O
MetSyn	O
.	O

No	O
dose	O
response	O
relationship	O
was	O
determined	O
with	O
PA	B-Physical_activity
and	O
MetSyn	O
.	O

The	O
odds	O
of	O
having	O
MetSyn	O
was	O
significantly	O
higher	O
for	O
sedentary	O
workers	O
with	O
insufficient	O
LTPA	B-Physical_activity
compared	O
with	O
those	O
achieving	O
sufficient	O
LTPA	B-Physical_activity
.	O

The	O
odds	O
for	O
MetSyn	O
were	O
similar	O
among	O
women	O
employed	O
in	O
moderately	B-Socioeconomic_factors
active	I-Socioeconomic_factors
or	I-Socioeconomic_factors
heavy	I-Socioeconomic_factors
work	I-Socioeconomic_factors
yet	O
completing	O
insufficient	O
LTPA	B-Physical_activity
compared	O
with	O
women	O
doing	O
sufficient	O
LTPA	B-Physical_activity
.	O

CONCLUSIONS	O
:	O
For	O
women	O
with	O
sedentary	B-Socioeconomic_factors
occupations	I-Socioeconomic_factors
,	O
a	O
sufficient	O
amount	O
of	O
LTPA	B-Physical_activity
is	O
essential	O
to	O
reduce	O
the	O
risk	O
of	O
having	O
the	O
MetSyn	O
.	O

Women	O
in	O
moderate	B-Socioeconomic_factors
to	I-Socioeconomic_factors
heavy	I-Socioeconomic_factors
working	I-Socioeconomic_factors
occupations	I-Socioeconomic_factors
may	O
be	O
acquiring	O
adequate	O
amounts	O
of	O
PA	B-Physical_activity
to	O
avoid	O
having	O
the	O
MetSyn	O
.	O

Segmentation	O
in	O
low	O
-	O
penetration	O
and	O
low	O
-	O
involvement	O
categories	O
:	O
an	O
application	O
to	O
lottery	O
games	O
.	O

Market	O
segmentation	O
is	O
accepted	O
as	O
a	O
fundamental	O
concept	O
in	O
marketing	O
and	O
several	O
authors	O
have	O
recently	O
proposed	O
a	O
segmentation	O
model	O
where	O
personal	O
and	O
environmental	O
variables	O
intersect	O
with	O
each	O
other	O
to	O
form	O
motivating	O
conditions	O
that	O
drive	O
behavior	O
and	O
preferences	O
.	O

This	O
model	O
of	O
segmentation	O
has	O
been	O
applied	O
to	O
packaged	O
goods	O
.	O

This	O
paper	O
extends	O
this	O
literature	O
by	O
proposing	O
a	O
segmentation	O
model	O
for	O
low	O
-	O
penetration	O
and	O
low	O
involvement	O
(	O
LP	O
-	O
LI	O
)	O
products	O
.	O

An	O
application	O
to	O
the	O
lottery	O
games	O
in	O
Chile	O
supports	O
the	O
proposed	O
model	O
.	O

The	O
results	O
of	O
the	O
study	O
show	O
that	O
in	O
this	O
type	O
of	O
products	O
(	O
LP	O
-	O
LI	O
)	O
,	O
the	O
attitude	O
towards	O
the	O
product	O
category	O
is	O
the	O
most	O
important	O
factor	O
that	O
distinguishes	O
consumers	O
from	O
non	O
consumers	O
,	O
and	O
heavy	O
users	O
from	O
light	O
users	O
,	O
and	O
consequently	O
,	O
a	O
critical	O
segmentation	O
variable	O
.	O

In	O
addition	O
,	O
a	O
cluster	O
analysis	O
shows	O
the	O
existence	O
of	O
three	O
segments	O
:	O
(	O
1	O
)	O
the	O
impulsive	O
dreamers	O
,	O
who	O
believe	O
in	O
chance	O
,	O
and	O
in	O
that	O
lottery	O
games	O
can	O
change	O
their	O
life	O
,	O
(	O
2	O
)	O
the	O
skeptical	O
,	O
that	O
do	O
not	O
believe	O
in	O
chance	O
,	O
nor	O
in	O
that	O
lottery	O
games	O
can	O
change	O
their	O
life	O
and	O
(	O
3	O
)	O
the	O
willing	O
,	O
who	O
value	O
the	O
benefits	O
of	O
playing	O
.	O

Optimization	O
of	O
a	O
fermented	B-Nutrition
soy	I-Nutrition
product	I-Nutrition
formulation	O
with	O
a	O
kefir	B-Nutrition
culture	O
and	O
fiber	B-Nutrition
using	O
a	O
simplex	O
-	O
centroid	O
mixture	O
design	O
.	O

The	O
objective	O
of	O
this	O
work	O
was	O
to	O
optimize	O
a	O
fermented	B-Nutrition
soy	I-Nutrition
product	I-Nutrition
formulation	O
with	O
kefir	B-Nutrition
and	O
soy	B-Nutrition
,	O
oat	B-Nutrition
and	O
wheat	B-Nutrition
fibers	I-Nutrition
and	O
to	O
evaluate	O
the	O
fiber	B-Nutrition
and	O
product	B-Nutrition
characteristics	O
.	O

A	O
simplex	O
-	O
centroid	O
mixture	O
design	O
was	O
used	O
for	O
the	O
optimization	O
.	O

Soymilk	B-Nutrition
,	O
soy	B-Nutrition
,	O
oat	B-Nutrition
and	O
wheat	B-Nutrition
fiber	I-Nutrition
mixtures	O
,	O
sucrose	B-Nutrition
and	O
anti	B-Nutrition
-	I-Nutrition
foaming	I-Nutrition
agent	I-Nutrition
were	O
used	O
for	O
the	O
formulation	O
,	O
followed	O
by	O
thermal	B-Nutrition
treatment	I-Nutrition
,	O
cooling	B-Nutrition
and	O
the	O
addition	O
of	O
flavoring	B-Nutrition
.	O

Fermentation	B-Nutrition
was	O
performed	O
at	O
25	O
degreesC	O
with	O
a	O
kefir	B-Nutrition
culture	O
until	O
a	O
pH	O
of	O
4	O
.	O
5	O
was	O
obtained	O
.	O

The	O
products	B-Nutrition
were	O
cooled	O
,	O
homogenized	O
and	O
stored	O
for	O
analysis	O
.	O

From	O
the	O
mathematical	O
models	O
and	O
variables	O
response	O
surface	O
and	O
desirability	O
an	O
optimal	O
fermented	B-Nutrition
product	I-Nutrition
was	O
formulated	O
containing	O
3	O
%	O
(	O
w	O
/	O
w	O
)	O
soy	B-Nutrition
fiber	I-Nutrition
.	O

Compared	O
with	O
the	O
other	O
formulations	O
,	O
soy	B-Nutrition
fermented	I-Nutrition
product	I-Nutrition
with	O
3	O
%	O
soy	B-Nutrition
fiber	I-Nutrition
had	O
the	O
best	O
acidity	O
,	O
viscosity	O
,	O
syneresis	O
,	O
firmness	O
and	O
Lactococcus	O
lactis	O
count	O
.	O

Practical	O
issues	O
and	O
the	O
assessment	O
of	O
pathological	O
gamblers	O
in	O
a	O
private	O
practice	O
setting	O
.	O

With	O
increased	O
awareness	O
and	O
knowledge	O
of	O
pathological	O
gambling	B-Non_physical_leisure_time_activities
comes	O
the	O
opportunity	O
to	O
share	O
various	O
perspectives	O
and	O
emerging	O
skills	O
.	O

Descriptions	O
of	O
the	O
assessment	O
and	O
treatment	O
of	O
the	O
pathological	O
gambler	O
,	O
spouse	O
,	O
and	O
family	O
have	O
mushroomed	O
in	O
the	O
past	O
twenty	O
years	O
.	O

However	O
,	O
most	O
treatment	O
summaries	O
have	O
come	O
out	O
of	O
institutional	O
or	O
government	O
funded	O
settings	O
.	O

This	O
article	O
discusses	O
various	O
practical	O
aspects	O
of	O
working	O
with	O
pathological	O
gamblers	O
in	O
an	O
outpatient	O
,	O
fee	O
for	O
service	O
private	O
practice	O
setting	O
.	O

The	O
author	O
also	O
describes	O
refinements	O
made	O
in	O
the	O
assessment	O
process	O
since	O
he	O
first	O
began	O
working	O
with	O
pathological	O
gamblers	O
in	O
1979	O
.	O

Extended	O
regimens	O
of	O
combined	O
hormonal	B-Socioeconomic_factors
contraception	I-Socioeconomic_factors
to	O
reduce	O
symptoms	O
related	O
to	O
withdrawal	O
bleeding	O
and	O
the	O
hormone	O
-	O
free	O
interval	O
:	O
a	O
systematic	O
review	O
of	O
randomised	O
and	O
observational	O
studies	O
.	O

OBJECTIVE	O
:	O
To	O
assess	O
whether	O
continuous	O
and	O
extended	O
regimens	O
(	O
CRs	O
/	O
ERs	O
)	O
of	O
combined	B-Socioeconomic_factors
hormonal	I-Socioeconomic_factors
contraceptives	I-Socioeconomic_factors
(	O
CHCs	B-Socioeconomic_factors
)	O
improve	O
symptoms	O
related	O
to	O
withdrawal	O
bleeding	O
or	O
the	O
hormone	O
-	O
free	O
interval	O
and	O
to	O
compare	O
the	O
efficacy	O
,	O
safety	O
,	O
and	O
cost	O
of	O
CRs	O
/	O
ERs	O
to	O
those	O
of	O
conventional	O
28	O
-	O
day	O
regimens	O
.	O

STUDY	O
DESIGN	O
:	O
A	O
literature	O
search	O
of	O
the	O
PubMed	O
database	O
was	O
conducted	O
for	O
randomised	O
clinical	O
trials	O
(	O
RCTs	O
)	O
and	O
observational	O
studies	O
published	O
in	O
any	O
language	O
between	O
2006	O
and	O
2013	O
.	O

RESULTS	O
:	O
Sixteen	O
RCTs	O
and	O
14	O
observational	O
studies	O
evaluated	O
issues	O
related	O
to	O
our	O
objectives	O
.	O

CRs	O
/	O
ERs	O
,	O
whose	O
efficacy	O
and	O
safety	O
were	O
comparable	O
to	O
those	O
described	O
for	O
conventional	O
regimens	O
,	O
were	O
preferred	O
due	O
to	O
their	O
improvement	O
of	O
symptoms	O
related	O
to	O
withdrawal	O
bleeding	O
or	O
the	O
hormone	O
-	O
free	O
interval	O
and	O
the	O
lower	O
costs	O
resulting	O
from	O
the	O
reduced	O
incidence	O
of	O
these	O
symptoms	O
.	O

CONCLUSION	O
:	O
The	O
contraceptive	B-Socioeconomic_factors
efficacy	O
and	O
safety	O
of	O
CR	O
/	O
ER	O
use	O
of	O
CHCs	B-Socioeconomic_factors
is	O
at	O
least	O
equal	O
to	O
that	O
of	O
28	O
-	O
days	O
conventional	O
regimens	O
,	O
and	O
this	O
use	O
may	O
have	O
some	O
cost	O
savings	O
.	O

CRs	O
/	O
ERs	O
are	O
recommended	O
for	O
women	O
willing	O
to	O
take	O
a	O
CHC	B-Socioeconomic_factors
for	O
treatment	O
of	O
symptoms	O
related	O
to	O
withdrawal	O
bleeding	O
or	O
the	O
hormone	O
-	O
free	O
interval	O
.	O

Cognitive	O
function	O
during	O
low	B-Physical_activity
-	I-Physical_activity
intensity	I-Physical_activity
walking	I-Physical_activity
:	O
a	O
test	O
of	O
the	O
treadmill	B-Physical_activity
workstation	O
.	O

BACKGROUND	O
:	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
effects	O
of	O
walking	B-Physical_activity
at	I-Physical_activity
self	I-Physical_activity
-	I-Physical_activity
selected	I-Physical_activity
speed	I-Physical_activity
on	O
an	O
active	O
workstation	O
on	O
cognitive	O
performance	O
.	O

METHODS	O
:	O
Sixty	O
-	O
six	O
participants	O
(	O
n	O
=	O
27	O
males	O
,	O
39	O
females	O
;	O
mean	O
age	O
=	O
21	O
.	O
06	O
+	O
/	O
-	O
1	O
.	O
6	O
years	O
)	O
completed	O
a	O
treadmill	B-Physical_activity
-	I-Physical_activity
desk	I-Physical_activity
walking	B-Physical_activity
and	O
a	O
seated	O
control	O
condition	O
,	O
separated	O
by	O
48	O
hours	O
.	O

During	O
each	O
condition	O
,	O
participants	O
completed	O
computerized	O
versions	O
of	O
the	O
Stroop	O
test	O
,	O
a	O
modified	O
flanker	O
task	O
,	O
and	O
a	O
test	O
of	O
reading	O
comprehension	O
.	O

RESULTS	O
:	O
No	O
significant	O
differences	O
in	O
response	O
speed	O
or	O
accuracy	O
were	O
found	O
between	O
walking	B-Physical_activity
and	O
sitting	B-Physical_activity
conditions	O
for	O
any	O
the	O
cognitive	O
tests	O
.	O

CONCLUSIONS	O
:	O
These	O
findings	O
reveal	O
that	O
performance	O
on	O
cognitive	O
tasks	O
,	O
including	O
executive	O
control	O
processes	O
,	O
are	O
not	O
impaired	O
by	O
walking	B-Physical_activity
on	O
an	O
active	O
workstation	O
.	O

Implementing	O
active	O
workstations	O
into	O
offices	O
and	O
classrooms	O
may	O
help	O
to	O
decrease	O
sedentariness	B-Physical_activity
without	O
impairing	O
task	O
performance	O
.	O

Stability	O
of	O
carotenoids	B-Nutrition
and	O
tocopherols	B-Nutrition
in	O
ready	O
-	O
to	O
-	O
eat	O
baby	B-Nutrition
-	I-Nutrition
leaf	I-Nutrition
lettuce	I-Nutrition
and	O
salad	B-Nutrition
rocket	I-Nutrition
during	O
low	O
-	O
temperature	O
storage	O
.	O

Minimally	O
processed	O
ready	O
-	O
to	O
-	O
eat	O
baby	B-Nutrition
-	I-Nutrition
leaf	I-Nutrition
vegetables	I-Nutrition
(	O
BLVs	B-Nutrition
)	O
are	O
the	O
most	O
convenient	O
source	O
to	O
include	O
the	O
health	O
beneficial	O
bioactive	O
in	O
the	O
daily	B-Nutrition
diet	I-Nutrition
.	O

In	O
the	O
present	O
study	O
,	O
the	O
visual	O
quality	O
and	O
storage	O
stability	O
of	O
carotenoids	B-Nutrition
,	O
tocopherols	B-Nutrition
were	O
investigated	O
in	O
lettuce	B-Nutrition
(	I-Nutrition
green	I-Nutrition
and	I-Nutrition
red	I-Nutrition
romaine	I-Nutrition
)	O
and	O
salad	B-Nutrition
rocket	I-Nutrition
BLVs	I-Nutrition
.	I-Nutrition

The	O
commercially	O
packed	O
samples	O
of	O
BLVs	B-Nutrition
were	O
stored	O
at	O
0	O
degreesC	O
and	O
4	O
degreesC	O
in	O
dark	O
conditions	O
and	O
analyzed	O
after	O
0	O
,	O
2	O
,	O
4	O
,	O
8	O
and	O
12	O
days	O
of	O
storage	O
.	O

All	O
the	O
studied	O
samples	O
were	O
found	O
in	O
better	O
visual	O
quality	O
up	O
to	O
eight	O
days	O
of	O
storage	O
at	O
both	O
the	O
temperatures	O
.	O

In	O
most	O
cases	O
,	O
the	O
quality	O
was	O
correlated	O
with	O
the	O
chlorophyll	O
contents	O
.	O

The	O
highest	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
positive	O
changes	O
in	O
total	O
carotenoids	B-Nutrition
and	O
tocopherols	B-Nutrition
were	O
observed	O
in	O
samples	O
stored	O
at	O
4	O
degreesC	O
.	O

Also	O
,	O
carotenoids	B-Nutrition
and	O
tocopherols	B-Nutrition
are	O
maximum	O
stable	O
in	O
green	B-Nutrition
and	I-Nutrition
red	I-Nutrition
romaine	I-Nutrition
lettuce	I-Nutrition
,	O
respectively	O
.	O

Cortical	O
and	O
Subcortical	O
Brain	O
Changes	O
in	O
Children	O
and	O
Adolescents	O
With	O
Narcolepsy	O
Type	O
1	O
.	O

STUDY	O
OBJECTIVES	O
:	O
Neuroimaging	O
studies	O
on	O
structural	O
alterations	O
in	O
patients	O
with	O
type	O
1	O
narcolepsy	O
(	O
NT1	O
)	O
have	O
shown	O
controversial	O
and	O
heterogeneous	O
results	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
microstructural	O
brain	O
changes	O
in	O
patients	O
with	O
NT1	O
close	O
to	O
disease	O
onset	O
.	O

METHODS	O
:	O
We	O
examined	O
cortical	O
and	O
subcortical	O
grey	O
matter	O
volumes	O
in	O
20	O
drug	O
-	O
naive	O
children	O
and	O
adolescents	O
with	O
NT1	O
compared	O
with	O
19	O
healthy	O
controls	O
;	O
whole	O
-	O
brain	O
voxel	O
-	O
based	O
morphometry	O
,	O
shape	O
and	O
volumetric	O
analyses	O
,	O
and	O
cortical	O
thickness	O
analysis	O
were	O
used	O
.	O

RESULTS	O
:	O
When	O
compared	O
with	O
controls	O
,	O
NT1	O
patients	O
revealed	O
reduced	O
grey	O
matter	O
volume	O
in	O
cerebellum	O
and	O
medial	O
prefrontal	O
cortex	O
and	O
increased	O
volume	O
in	O
right	O
hippocampus	O
.	O

Cortical	O
thickness	O
in	O
frontal	O
lobe	O
was	O
also	O
reduced	O
in	O
patients	O
compared	O
with	O
controls	O
.	O

Increased	O
volume	O
and	O
shape	O
expansion	O
in	O
right	O
hippocampus	O
in	O
patients	O
compared	O
with	O
controls	O
were	O
also	O
confirmed	O
by	O
both	O
vertex	O
and	O
volumetric	O
analyses	O
.	O

CONCLUSIONS	O
:	O
Our	O
results	O
indicate	O
that	O
subtle	O
structural	O
brain	O
changes	O
involving	O
attentional	O
and	O
limbic	O
circuits	O
are	O
detectable	O
in	O
children	O
and	O
adolescents	O
with	O
NT1	O
.	O

Cerebellum	O
involvement	O
might	O
be	O
related	O
to	O
the	O
childhood	O
NT1	O
clinical	O
phenotype	O
.	O

A	O
chemical	O
dynamic	O
model	O
for	O
the	O
infiltration	O
of	O
outdoor	O
size	O
-	O
resolved	O
ammonium	B-Environmental_exposures
nitrate	I-Environmental_exposures
aerosols	I-Environmental_exposures
to	O
indoor	O
environments	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
developed	O
a	O
chemical	O
dynamic	O
model	O
to	O
describe	O
the	O
infiltration	O
of	O
size	O
-	O
resolved	O
ammonium	B-Environmental_exposures
nitrate	I-Environmental_exposures
aerosols	I-Environmental_exposures
from	O
outdoor	O
to	O
indoor	O
environments	O
.	O

This	O
model	O
considered	O
the	O
penetration	O
factor	O
,	O
deposition	O
rate	O
,	O
and	O
the	O
reversible	O
reaction	O
process	O
,	O
which	O
was	O
quantified	O
by	O
the	O
diffusive	O
molar	O
flux	O
on	O
the	O
surface	O
of	O
ammonium	B-Environmental_exposures
nitrate	I-Environmental_exposures
aerosols	I-Environmental_exposures
depending	O
on	O
indoor	O
temperature	O
,	O
humidity	O
,	O
and	O
concentrations	O
of	O
nitric	O
acid	O
(	O
HNO3	O
)	O
and	O
ammonia	O
(	O
NH3	O
)	O
.	O

To	O
verify	O
the	O
model	O
,	O
we	O
employed	O
a	O
single	O
-	O
particle	O
aerosol	O
mass	O
spectrometer	O
with	O
an	O
automated	O
switching	O
system	O
to	O
simultaneously	O
measure	O
size	O
-	O
resolved	O
outdoor	O
and	O
indoor	O
ammonium	B-Environmental_exposures
nitrate	I-Environmental_exposures
aerosols	I-Environmental_exposures
.	O

Comparisons	O
between	O
the	O
predicted	O
and	O
measured	O
concentrations	O
of	O
these	O
aerosols	B-Environmental_exposures
showed	O
a	O
mean	O
relative	O
error	O
of	O
4	O
.	O
8	O
+	O
/	O
-	O
18	O
.	O
3	O
%	O
.	O

To	O
analyze	O
the	O
sensitivity	O
of	O
model	O
parameters	O
,	O
several	O
parameters	O
were	O
perturbed	O
.	O

This	O
analysis	O
indicated	O
that	O
parameters	O
related	O
to	O
HNO3	O
were	O
more	O
sensitive	O
than	O
those	O
related	O
to	O
NH3	O
because	O
the	O
indoor	O
gas	O
phase	O
concentration	O
of	O
NH3	O
was	O
much	O
higher	O
than	O
that	O
of	O
HNO3	O
.	O

The	O
Effect	O
of	O
Pre	O
-	O
Post	O
Differences	O
in	O
Walking	B-Physical_activity
,	O
Health	O
,	O
and	O
Weight	O
on	O
Retirees	O
'	O
Long	O
-	O
Term	O
Quality	O
of	O
Life	O
.	O

This	O
research	O
examined	O
the	O
effect	O
of	O
pre	O
-	O
post	O
differences	O
in	O
walking	B-Physical_activity
duration	I-Physical_activity
,	O
health	O
,	O
and	O
weight	O
on	O
retirees	O
'	O
long	O
-	O
term	O
quality	O
of	O
life	O
(	O
QoL	O
)	O
.	O

It	O
used	O
data	O
from	O
a	O
2018	O
randomized	O
mail	O
survey	O
of	O
483	O
suburban	O
New	O
Jersey	O
retirees	O
.	O

Ordinary	O
least	O
squares	O
and	O
three	O
-	O
stage	O
least	O
squares	O
models	O
were	O
used	O
.	O

The	O
analysis	O
showed	O
that	O
changes	O
in	O
walking	B-Physical_activity
duration	I-Physical_activity
during	O
the	O
first	O
2	O
years	O
of	O
retirement	B-Socioeconomic_factors
are	O
directly	O
associated	O
with	O
health	O
change	O
,	O
health	O
change	O
has	O
an	O
effect	O
on	O
long	O
-	O
term	O
QoL	O
,	O
and	O
weight	O
variation	O
of	O
10	O
lb	O
or	O
more	O
has	O
an	O
effect	O
on	O
health	O
change	O
and	O
long	O
-	O
term	O
QoL	O
.	O

Although	O
QoL	O
peaks	O
for	O
the	O
sample	O
of	O
retirees	O
at	O
around	O
age	O
75	O
,	O
people	O
whose	O
average	O
walking	B-Physical_activity
duration	I-Physical_activity
increased	O
,	O
health	O
improved	O
,	O
and	O
weight	O
did	O
not	O
increase	O
substantially	O
after	O
retirement	B-Socioeconomic_factors
continued	O
to	O
experience	O
high	O
QoL	O
for	O
a	O
longer	O
time	O
.	O

The	O
results	O
show	O
that	O
people	O
can	O
achieve	O
high	O
long	O
-	O
term	O
QoL	O
by	O
choosing	O
an	O
active	B-Physical_activity
lifestyle	I-Physical_activity
when	O
transitioning	O
to	O
retirement	B-Socioeconomic_factors
.	O

Reducing	O
Anxiety	O
and	O
Anxiety	O
Sensitivity	O
With	O
High	B-Physical_activity
-	I-Physical_activity
Intensity	I-Physical_activity
Interval	I-Physical_activity
Training	I-Physical_activity
in	O
Adults	O
With	O
Asthma	O
.	O

BACKGROUND	O
:	O
Low	B-Physical_activity
-	I-Physical_activity
and	I-Physical_activity
moderate	I-Physical_activity
-	I-Physical_activity
intensity	I-Physical_activity
exercise	I-Physical_activity
training	I-Physical_activity
has	O
been	O
shown	O
to	O
be	O
effective	O
for	O
reducing	O
general	O
anxiety	O
and	O
anxiety	O
sensitivity	O
among	O
adults	O
with	O
asthma	O
.	O

Exercise	B-Physical_activity
frequency	I-Physical_activity
and	I-Physical_activity
intensity	I-Physical_activity
have	O
been	O
shown	O
to	O
play	O
an	O
integral	O
role	O
in	O
reducing	O
anxiety	O
sensitivity	O
;	O
however	O
,	O
less	O
is	O
known	O
about	O
the	O
impact	O
of	O
high	B-Physical_activity
-	I-Physical_activity
intensity	I-Physical_activity
interval	I-Physical_activity
training	I-Physical_activity
(	O
HIIT	B-Physical_activity
)	O
on	O
anxiety	O
in	O
adults	O
with	O
asthma	O
.	O

METHODS	O
:	O
A	O
6	O
-	O
week	O
HIIT	B-Physical_activity
intervention	O
was	O
conducted	O
with	O
adults	O
with	O
asthma	O
.	O

Participants	O
completed	O
HIIT	B-Physical_activity
(	O
10	O
%	O
peak	O
power	O
output	O
for	O
1	O
min	O
,	O
90	O
%	O
peak	O
power	O
output	O
for	O
1	O
min	O
,	O
repeated	O
10	O
times	O
)	O
3	O
times	O
per	O
week	O
on	O
a	O
cycle	O
ergometer	O
.	O

Preintervention	O
and	O
postintervention	O
assessments	O
included	O
the	O
Anxiety	O
Sensitivity	O
Index	O
-	O
3	O
and	O
the	O
Body	O
Sensations	O
Questionnaire	O
.	O

RESULTS	O
:	O
Total	O
Anxiety	O
Sensitivity	O
Index	O
-	O
3	O
(	O
PRE	O
:	O
17	O
.	O
9	O
[	O
11	O
.	O
8	O
]	O
;	O
POST	O
12	O
.	O
4	O
[	O
13	O
]	O
,	O
P	O
=	O
.	O
002	O
,	O
Cohen	O
d	O
=	O
0	O
.	O
4	O
,	O
n	O
=	O
20	O
)	O
and	O
Body	O
Sensations	O
Questionnaire	O
(	O
PRE	O
:	O
2	O
.	O
4	O
[	O
1	O
.	O
0	O
]	O
;	O
POST	O
:	O
2	O
.	O
0	O
[	O
0	O
.	O
8	O
]	O
,	O
P	O
=	O
.	O
007	O
,	O
Cohen	O
d	O
=	O
0	O
.	O
3	O
)	O
improved	O
from	O
preintervention	O
to	O
postintervention	O
.	O

CONCLUSION	O
:	O
A	O
6	O
-	O
week	O
HIIT	B-Physical_activity
intervention	O
leads	O
to	O
improved	O
anxiety	O
among	O
adults	O
with	O
asthma	O
.	O

Future	O
research	O
should	O
determine	O
the	O
impact	O
of	O
HIIT	B-Physical_activity
among	O
adults	O
with	O
asthma	O
with	O
clinical	O
anxiety	O
.	O

Evaluating	O
national	O
and	O
subnational	O
CO2	B-Environmental_exposures
mitigation	O
goals	O
in	O
China	O
'	O
s	O
thirteenth	O
five	O
-	O
year	O
plan	O
from	O
satellite	O
observations	O
.	O

Good	O
-	O
quality	O
emission	O
data	O
are	O
essential	O
to	O
validate	O
national	O
climate	B-Environmental_exposures
commitments	O
and	O
implement	O
domestic	O
policies	O
.	O

However	O
,	O
conventional	O
bottom	O
-	O
up	O
data	O
collection	O
is	O
costly	O
and	O
subject	O
to	O
potential	O
manipulation	O
by	O
stakeholders	O
when	O
data	O
pass	O
through	O
their	O
hands	O
,	O
which	O
could	O
pose	O
challenges	O
on	O
the	O
efficiency	O
and	O
effectiveness	O
of	O
compliance	O
monitoring	O
especially	O
in	O
developing	B-Socioeconomic_factors
countries	I-Socioeconomic_factors
.	O

Satellite	O
observations	O
,	O
specifically	O
OCO	O
-	O
2	O
XCO2	O
measurements	O
,	O
are	O
utilized	O
in	O
this	O
study	O
to	O
develop	O
a	O
relatively	O
independent	O
and	O
timely	O
dataset	O
for	O
screening	O
the	O
attainment	O
statuses	O
of	O
national	O
and	O
subnational	O
CO2	B-Environmental_exposures
mitigation	O
goals	O
in	O
China	O
'	O
s	O
13th	O
Five	O
-	O
Year	O
Plan	O
(	O
FYP	O
,	O
2016	O
-	O
2020	O
)	O
.	O

We	O
establish	O
CO2	B-Environmental_exposures
emission	I-Environmental_exposures
estimation	O
models	O
at	O
both	O
pixel	O
and	O
provincial	O
levels	O
.	O

As	O
interpolated	O
with	O
the	O
pixel	O
-	O
level	O
model	O
,	O
CO2	B-Environmental_exposures
emissions	I-Environmental_exposures
of	O
prefecture	O
-	O
level	O
municipalities	O
indicate	O
that	O
approximately	O
three	O
fifth	O
of	O
them	O
had	O
accomplished	O
their	O
individualized	O
FYP	O
mitigation	O
goals	O
by	O
2019	O
,	O
while	O
our	O
provincial	O
-	O
level	O
estimation	O
suggests	O
that	O
three	O
quarters	O
of	O
provinces	O
had	O
attained	O
theirs	O
.	O

More	O
resources	O
for	O
compliance	O
monitoring	O
could	O
thus	O
be	O
directed	O
to	O
other	O
presumably	O
-	O
unattaining	O
local	O
governments	O
.	O

National	O
aggregate	O
absolute	O
emissions	B-Environmental_exposures
showed	O
8	O
.	O
0	O
-	O
18	O
.	O
3	O
%	O
reduction	O
in	O
2019	O
across	O
three	O
provincial	O
models	O
from	O
the	O
2015	O
level	O
,	O
while	O
national	O
CO2	O
intensity	O
dropped	O
by	O
28	O
.	O
8	O
-	O
36	O
.	O
8	O
%	O
to	O
imply	O
attaining	O
the	O
18	O
%	O
reduction	O
goals	O
.	O

Strategic	O
and	O
contested	O
use	O
of	O
food	O
laws	O
to	O
ban	O
smokeless	B-Drugs
tobacco	I-Drugs
products	I-Drugs
in	O
India	O
:	O
a	O
qualitative	O
analysis	O
of	O
litigation	O
.	O

OBJECTIVE	O
:	O
To	O
understand	O
how	O
food	O
laws	O
are	O
used	O
,	O
contested	O
and	O
interpreted	O
to	O
ban	O
certain	O
forms	O
of	O
chewing	B-Drugs
tobacco	I-Drugs
in	O
India	O
.	O

METHODS	O
:	O
A	O
qualitative	O
study	O
analysing	O
all	O
the	O
tobacco	B-Drugs
-	O
related	O
litigation	O
under	O
the	O
food	O
laws	O
in	O
India	O
.	O

We	O
used	O
an	O
inductive	O
thematic	O
analysis	O
of	O
the	O
litigation	O
contents	O
.	O

RESULTS	O
:	O
The	O
tobacco	O
industry	O
systematically	O
deployed	O
litigation	O
to	O
(	O
1	O
)	O
challenge	O
the	O
categorisation	O
of	O
smokeless	B-Drugs
tobacco	I-Drugs
products	I-Drugs
as	O
food	B-Nutrition
,	O
and	O
hence	O
,	O
questioned	O
the	O
use	O
of	O
food	O
laws	O
for	O
regulating	O
these	O
products	B-Drugs
;	O
(	O
2	O
)	O
challenge	O
the	O
regulatory	O
power	O
of	O
the	O
state	O
government	O
in	O
banning	O
tobacco	B-Drugs
products	I-Drugs
via	O
the	O
food	O
laws	O
;	O
and	O
(	O
3	O
)	O
challenge	O
the	O
applicability	O
of	O
the	O
general	O
food	O
laws	O
that	O
enabled	O
stricter	O
regulations	O
beyond	O
what	O
is	O
prescribed	O
under	O
the	O
tobacco	O
-	O
specific	O
law	O
.	O

CONCLUSION	O
:	O
Despite	O
facing	O
several	O
legal	O
challenges	O
from	O
the	O
tobacco	O
industry	O
,	O
Indian	O
states	O
optimised	O
food	O
laws	O
to	O
enable	O
stricter	O
regulations	O
on	O
smokeless	B-Drugs
tobacco	I-Drugs
products	I-Drugs
than	O
were	O
feasible	O
through	O
use	O
of	O
a	O
tobacco	O
-	O
specific	O
law	O
.	O

Religion	B-Socioeconomic_factors
and	O
attitudes	O
towards	O
alcohol	B-Nutrition
use	I-Nutrition
in	O
the	O
Western	O
Isles	O
.	O

Research	O
on	O
religion	B-Socioeconomic_factors
and	O
alcohol	B-Nutrition
has	O
produced	O
conclusive	O
results	O
with	O
regard	O
to	O
the	O
relationship	O
between	O
religion	B-Socioeconomic_factors
and	O
alcohol	B-Nutrition
consumption	I-Nutrition
but	O
ambiguous	O
findings	O
with	O
regard	O
to	O
more	O
general	O
attitudes	O
towards	O
alcohol	B-Nutrition
use	I-Nutrition
.	O

This	O
paper	O
considers	O
these	O
issues	O
in	O
depth	O
by	O
a	O
secondary	O
analysis	O
of	O
data	O
collected	O
in	O
the	O
Western	O
Isles	O
of	O
Scotland	O
.	O

It	O
finds	O
that	O
differences	O
between	O
Protestants	O
and	O
Catholics	O
do	O
exist	O
:	O
Protestants	O
are	O
more	O
likely	O
to	O
endorse	O
an	O
abstinent	O
position	O
,	O
while	O
Catholics	O
are	O
more	O
permissive	O
in	O
their	O
attitudes	O
towards	O
drinking	B-Nutrition
.	O

In	O
terms	O
of	O
attitudes	O
towards	O
drunkenness	B-Nutrition
,	O
however	O
,	O
differences	O
between	O
the	O
two	O
groups	O
are	O
slight	O
.	O

The	O
paper	O
concludes	O
by	O
giving	O
data	O
on	O
differences	O
in	O
attitudes	O
towards	O
alcoholism	B-Nutrition
and	O
service	O
use	O
and	O
calls	O
for	O
future	O
studies	O
in	O
the	O
area	O
to	O
take	O
the	O
cultural	O
context	O
of	O
these	O
issues	O
into	O
account	O
.	O

SCAN	O
:	O
a	O
method	O
of	O
community	O
collaboration	O
.	O

Recent	O
research	O
has	O
highlighted	O
the	O
complexity	O
of	O
the	O
battered	O
child	O
syndrome	O
.	O

Clinical	O
experience	O
suggests	O
that	O
treatment	O
of	O
troubled	B-Socioeconomic_factors
families	I-Socioeconomic_factors
is	O
a	O
long	O
-	O
term	O
process	O
,	O
draining	O
financial	O
resources	O
of	O
agencies	O
and	O
emotional	O
resources	O
of	O
professionals	O
.	O

The	O
need	O
to	O
provide	O
support	O
and	O
case	O
consultation	O
to	O
professionals	O
working	O
in	O
the	O
area	O
of	O
child	B-Socioeconomic_factors
abuse	I-Socioeconomic_factors
and	I-Socioeconomic_factors
neglect	I-Socioeconomic_factors
evolved	O
in	O
the	O
establishment	O
,	O
in	O
1968	O
,	O
of	O
the	O
Suspected	O
Child	O
Abuse	O
and	O
Neglect	O
(	O
SCAN	O
)	O
Program	O
at	O
Children	O
'	O
s	O
Hospital	O
,	O
Pittsburgh	O
,	O
Pennsylvania	O
.	O

This	O
program	O
provides	O
an	O
effective	O
method	O
of	O
intervention	O
through	O
identification	O
,	O
consultation	O
,	O
referral	O
and	O
follow	O
-	O
up	O
of	O
at	O
-	O
risk	O
families	O
.	O

Weekly	O
meetings	O
offer	O
multi	O
-	O
disciplinary	O
case	O
coordination	O
,	O
treatment	O
recommendations	O
,	O
and	O
a	O
channel	O
of	O
communication	O
for	O
representatives	O
of	O
community	O
agencies	O
.	O

This	O
paper	O
traces	O
the	O
history	O
and	O
present	O
status	O
of	O
the	O
SCAN	O
Program	O
,	O
as	O
well	O
as	O
the	O
role	O
of	O
SCAN	O
as	O
a	O
force	O
for	O
change	O
of	O
community	O
attitudes	O
.	O

Oral	B-Socioeconomic_factors
contraceptives	I-Socioeconomic_factors
and	O
venous	O
thromboembolism	O
:	O
an	O
epidemiological	O
review	O
.	O

New	O
epidemiological	O
studies	O
have	O
demonstrated	O
a	O
higher	O
risk	O
of	O
venous	O
thromboembolism	O
among	O
users	O
of	O
oral	B-Socioeconomic_factors
contraceptives	I-Socioeconomic_factors
(	O
OCs	B-Socioeconomic_factors
)	O
with	O
third	O
-	O
generation	O
progestogens	B-Socioeconomic_factors
desogestrel	B-Socioeconomic_factors
or	O
gestodene	B-Socioeconomic_factors
compared	O
with	O
users	O
of	O
OCs	B-Socioeconomic_factors
with	O
second	O
-	O
generation	O
progestogens	B-Socioeconomic_factors
levonorgestrel	B-Socioeconomic_factors
or	O
norgestrel	B-Socioeconomic_factors
.	O

As	O
the	O
absolute	O
risk	O
of	O
venous	O
thromboembolism	O
among	O
users	O
of	O
OCs	B-Socioeconomic_factors
in	O
general	O
is	O
lower	O
in	O
the	O
new	O
studies	O
than	O
in	O
previously	O
published	O
studies	O
,	O
and	O
as	O
several	O
important	O
potential	O
confounders	O
are	O
not	O
controlled	O
for	O
in	O
the	O
new	O
studies	O
,	O
the	O
real	O
difference	O
in	O
risk	O
of	O
venous	O
thromboembolism	O
between	O
users	O
of	O
third	O
-	O
compared	O
with	O
second	O
-	O
generation	O
products	O
may	O
be	O
smaller	O
than	O
indicated	O
in	O
these	O
new	O
studies	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
risk	O
of	O
myocardial	O
infarction	O
may	O
be	O
smaller	O
among	O
users	O
of	O
third	O
-	O
compared	O
with	O
users	O
of	O
second	O
-	O
generation	O
products	O
.	O

Until	O
further	O
epidemiological	O
data	O
emerge	O
,	O
it	O
is	O
therefore	O
difficult	O
to	O
make	O
general	O
recommendations	O
other	O
than	O
to	O
use	O
OCs	B-Socioeconomic_factors
with	O
a	O
low	O
estrogen	O
dose	O
,	O
and	O
to	O
make	O
individual	O
recommendations	O
based	O
on	O
age	O
,	O
individual	O
wish	O
,	O
and	O
individual	O
risk	O
factors	O
.	O

